Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA-based copy number analysis confirms genomic evolution of PDX models
Anna C. H. Hoge, Michal Getz, Anat Zimmer, et al.
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 25

Showing 25 citing articles:

Patient-derived xenograft models in cancer therapy: technologies and applications
Yihan Liu, Wantao Wu, Changjing Cai, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 185
Towards precision oncology with patient-derived xenografts
Eugenia R. Zanella, Elena Grassi, Livio Trusolino
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 11, pp. 719-732
Closed Access | Times Cited: 88
Patient‐derived xenograft model in cancer: establishment and applications
Ao Gu, Jiatong Li, Mengyao Li, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 7
Preclinical models in head and neck squamous cell carcinoma
Patricia Cháves, Marı́a J. Garrido, Javier Oliver, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 10, pp. 1819-1827
Open Access | Times Cited: 26
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models
Robert E. Hynds, Ariana Huebner, David R. Pearce, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
The techniques and applications of patient-derived head and neck cancer organoids: a systematic review
Yangyang Xia, Shang Xie, Zhigang Cai, et al.
Holistic Integrative Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions
George Sflomos, Koen Schipper, Thijs Koorman, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5396-5396
Open Access | Times Cited: 34
Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations
Tiangen Chang, Yingying Cao, Eldad D. Shulman, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Capturing heterogeneity in PDX models: representation matters
Hari Shankar Sunil, Kathryn A. O’Donnell
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics
Lisa Bokhout, Joana D. Campeiro, Simone U. Dalm
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Molecular subtypes of bladder cancer do not display microenvironment- or metastasis-induced plasticity
Carina Bernardo, Subhayan Chattopadhyay, Natalie Andersson, et al.
Research Square (Research Square) (2025)
Closed Access
Identification of Molecular Subtypes of Clear-Cell Renal Cell Carcinoma in Patient-Derived Xenografts Using Multi-Omics
Zhengyuan Qiu, Dalin Zhang, Fernando Jose Garcia-Marques, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1361-1361
Open Access
Targeting vulnerabilities of aneuploid cells for cancer therapy
Johanna Zerbib, Amit Bloomberg, Uri Ben‐David
Trends in cancer (2025)
Closed Access
Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient’s response to conventional and novel therapies
Li‐Ting Liu, Min Wu, Anni Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity
Tom van den Bosch, Sarah Derks, Daniël M. Miedema
Cancers (2022) Vol. 14, Iss. 20, pp. 4986-4986
Open Access | Times Cited: 12
Genomic evolution of non-small cell lung cancer patient-derived xenograft models
Robert E. Hynds, Ariana Huebner, David R. Pearce, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer
Funan He, Abhik Bandyopadhyay, Laura J. Klesse, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Generation of post-surgical minimal residual disease models to investigate metastasis in soft tissue sarcoma patient-derived orthotopic xenografts
Suzanne Fischer, David Creytens, Stefanie Gijsels, et al.
STAR Protocols (2024) Vol. 5, Iss. 1, pp. 102863-102863
Open Access | Times Cited: 2
Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
Suzanne Fischer, David Creytens, Sofie De Geyter, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 5
The challenge of making the right choice: patient avatars in the era of cancer immunotherapies
Charlotte Kayser, Annika Bräuer, Sebens Susanne, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Generation and Integrated Analysis of Advanced Patient‐Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer
Laura Devis, August Vidal, Laura Plata‐Peña, et al.
Advanced Science (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment
Aki Morikawa, Jinju Li, Peter Ulintz, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 6, pp. 1093-1103
Open Access | Times Cited: 2
Patient-Derived-Xenografts in Mice: A Preclinical Platform for Cancer Research
Emiliano Cocco, Elisa de Stanchina
Cold Spring Harbor Perspectives in Medicine (2023) Vol. 14, Iss. 7, pp. a041381-a041381
Closed Access | Times Cited: 2
Data from Optimizing precision medicine for breast cancer brain metastases with functional drug response assessment.
Aki Morikawa, Jinju Li, Peter Ulintz, et al.
(2023)
Open Access
Data from Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment
Aki Morikawa, Jinju Li, Peter Ulintz, et al.
(2023)
Open Access
Page 1

Scroll to top